GPX4 and non-small cell lung carcinoma: The inhibitor for ferroptosis, ferrostatin-1 (fer-1), could reverse statin-induced GPX4 downregulation (Figure 6C) and could also reverse statin-induced cell death in NSCLC cells (Supplemental Figure 12, A and B).